EF-hands at atomic resolution: the structure of human psoriasin (S100A7) solved by MAD phasing
Structure, ISSN: 0969-2126, Vol: 6, Issue: 4, Page: 477-489
1998
- 95Citations
- 49Captures
- 1Mentions
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations95
- Citation Indexes95
- 95
- CrossRef70
- Captures49
- Readers49
- 49
- Mentions1
- References1
- Wikipedia1
Article Description
Background: The S100 family consists of small acidic proteins, belonging to the EF-hand class of calcium-binding proteins. They are primarily regulatory proteins, involved in cell growth, cell structure regulation and signal transduction. Psoriasin (S100A7) is an 11.7 kDa protein that is highly upregulated in the epidermis of patients suffering from the chronic skin disease psoriasis. Although its exact function is not known, psoriasin is believed to participate in the biochemical response which follows transient changes in the cellular Ca 2+ concentration.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0969212698000495; http://dx.doi.org/10.1016/s0969-2126(98)00049-5; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0032522812&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/9562557; http://linkinghub.elsevier.com/retrieve/pii/S0969212698000495; http://api.elsevier.com/content/article/PII:S0969212698000495?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S0969212698000495?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S0969212698000495; http://dx.doi.org/10.1016/s0969-2126%2898%2900049-5; http://www.cell.com/structure/abstract/S0969-2126(98)00049-5?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0969212698000495%3Fshowall%3Dtrue; https://secure.jbs.elsevierhealth.com/action/getSharedSiteSession?redirect=http%3A%2F%2Fwww.cell.com%2Fstructure%2Fabstract%2FS0969-2126%2898%2900049-5%3F_returnURL%3Dhttp%253A%252F%252Flinkinghub.elsevier.com%252Fretrieve%252Fpii%252FS0969212698000495%253Fshowall%253Dtrue&rc=0&code=cell-site; http://acw.elsevier.com/SSOCore?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.cell.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaaC02Fkp51A4hLPatTxv%2526MAID%253D2Rjq5p0PykzD37sdGKDXfw%25253D%25253D%2526SERVER%253DWZ6myaEXBLEIcey8uceZQQ%25253D%25253D%2526ORIGIN%253D143308024%2526RD%253DRD; http://acw.elsevier.com/SSOCore/?return=https%3A%2F%2Fsecure.jbs.elsevierhealth.com%2Faction%2FconsumeSsoCookie%3FredirectUri%3Dhttp%253A%252F%252Fwww.cell.com%252Faction%252FconsumeSharedSessionAction%253FJSESSIONID%253DaaaC02Fkp51A4hLPatTxv%2526MAID%253D2Rjq5p0PykzD37sdGKDXfw%25253D%25253D%2526SERVER%253DWZ6myaEXBLEIcey8uceZQQ%25253D%25253D%2526ORIGIN%253D143308024%2526RD%253DRD; https://secure.jbs.elsevierhealth.com/action/consumeSsoCookie?redirectUri=http%3A%2F%2Fwww.cell.com%2Faction%2FconsumeSharedSessionAction%3FJSESSIONID%3DaaaC02Fkp51A4hLPatTxv%26MAID%3D2Rjq5p0PykzD37sdGKDXfw%253D%253D%26SERVER%3DWZ6myaEXBLEIcey8uceZQQ%253D%253D%26ORIGIN%3D143308024%26RD%3DRD&acw=&utt=
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know